Johnson & Johnson Aktie
WKN: 853260 / ISIN: US4781601046
23.02.2021 03:38:06
|
Johnson & Johnson Sets Aside $3.9 Bln For Baby Powder Verdict, Settlements
(RTTNews) - Johnson & Johnson (JNJ) disclosed in a regulatory filing that it set aside a $3.9 billion to cover verdict against the company over its Baby Powder and other settlements.
The company reserved some of the money for a 2018 Missouri verdict for about 20 women who alleged that decades of daily use of Johnson & Johnson's asbestos-laden talcum powder products caused their ovarian cancer.
A Missouri appeals court in June 2020 reduced a damages award against Johnson & Johnson to about $2.12 billion from $4.69 billion.
The Missouri Supreme Court in November 2020 refused to consider J&J's arguments that the reduced verdict was flawed and excessive. The company is now asking the U.S. Supreme Court to throw the award out entirely.
In May 2020, Johnson & Johnson said it would stop selling its talc-based Johnson's Baby Powder in the United States and Canada, as demand fell amid mounting consumers lawsuits that claimed the talc products caused cancer.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Johnson & Johnsonmehr Nachrichten
16.05.25 |
Schwache Performance in New York: Dow Jones fällt mittags (finanzen.at) | |
14.05.25 |
Dow Jones-Handel aktuell: Dow Jones zum Ende des Mittwochshandels in der Verlustzone (finanzen.at) | |
14.05.25 |
Dow Jones aktuell: Dow Jones gibt am Mittwochnachmittag nach (finanzen.at) | |
14.05.25 |
Stabiler Handel: So performt der Dow Jones am Mittwochmittag (finanzen.at) | |
14.05.25 |
Dow Jones 30 Industrial-Wert Johnson Johnson-Aktie: So viel hätten Anleger an einem Johnson Johnson-Investment von vor 3 Jahren verloren (finanzen.at) | |
13.05.25 |
NYSE-Handel Dow Jones notiert schlussendlich im Minus (finanzen.at) | |
13.05.25 |
Börse New York in Rot: Dow Jones fällt zurück (finanzen.at) | |
13.05.25 |
Dow Jones-Handel aktuell: Das macht der Dow Jones aktuell (finanzen.at) |
Analysen zu Johnson & Johnsonmehr Analysen
Aktien in diesem Artikel
Johnson & Johnson | 135,26 | 1,35% |
|